ABSTRACT OBJECTIVES This study sought to evaluate whether the permanent fluoropolymer-coated Xience Xpedition everolimus-eluting stent (Xience-EES) exhibits lower acute thrombogenicity compared with contemporary drug-eluting stents (DES) with biodegradable polymer coatings in an acute swine shunt model. BACKGROUND Previous pre-clinical and clinical experience suggests that several factors may influence the predis-
arly stent thrombosis (ST) remains a critical issue even with the use of contemporary drug-eluting stents (DES), where the indications for percutaneous coronary intervention have been expanded to include more complex lesions (1, 2) . Histomorphologic assessment of stents at autopsy from patients presenting with acute coronary syndrome from our laboratory has demonstrated an association of early ST with necrotic core prolapse, medial tear, and incomplete stent apposition (3) .
In addition to morphologic criteria of the underlying plaque, stent design, choice of polymer coating, its application (e.g., use of primer, coating integrity), and drugs may also influence acute thrombogenicity as experimental studies in modified Chandler loops have shown that durable polymer-coated stents with thin struts exhibit less acute thrombogenicity with respect to platelet aggregation as compared to uncoated or stents with thicker struts (4) 
Ex Vivo Thrombogenicity in Contemporary DES deploying stents, the tubing was mounted in a fixed apparatus. The conduit was then filled with autologous serum and stents were expanded to a 3.0-mm diameter at nominal pressure. The extent of platelet aggregation to struts was studied after exposure to circulating blood for 1 h through an established arteriovenous carotid to jugular shunt. Otsuka et al.
Ex Vivo Thrombogenicity in Contemporary DES
A U G U S T 1 7 , 2 0 1 5 : 1 2 4 8 -6 0 formalin, and bisected longitudinally. One-half of each stent was immunostained using specific platelet markers relevant for aggregation of thrombocytes and examined en face by confocal microscopy, whereas the other one-half was processed for scanning electron microscopy (SEM). The statistical tests were 2-tailed and a value of p < 0.05 was considered to indicate statistical significance. Dunnett correction for many-to-1 comparisons was used to implement adjustment of p values and confidence interval lengths for multiple testing (10) .
RESULTS

BLOOD COAGULATION AND PLATELET FUNCTION.
There was no evidence of blood coagulation and platelet function abnormalities in any of the animals studied, and plasma pig platelet factor 4 release was below detection limit (Online Table 1 ). The mean activated clotting time was between 86 to 106 s at baseline, between 142 and 231 s during the first
Otsuka et al.
A U G U S T 1 7 , 2 0 1 5 : 1 2 4 8 -6 0
Ex Vivo Thrombogenicity in Contemporary DES shunt, and between 118 and 253 s during the second shunt (Online Table 1 ). Mean blood flow rates of shunts ranged from 93.22 to 164.62 ml/min and were similar among stent groups.
THROMBOGENICITY ASSESSED BY PLATELET IMMUNO-FLUORESCENCE. Representative confocal microscopy images of Xience-EES and comparator biodegradable polymer-coated DES are shown in Figure 2 . Otsuka et al. . Figures 3B and 6) .
DISCUSSION
In the present study, acute thrombogenicity with respect to platelet aggregation and inflammatory cell adhesion was compared among contemporary dura- CI ¼ confidence interval; other abbreviations as in Table 1 .
Otsuka et al. Xience-EES as compared with the other 4 CE-marked biodegradable polymer-coated DES. Abbreviations as in Figures 1 and 2 . Upper pair of rows shows adherent thrombi whereas the lower rows represent inflammation (original magnification: upper and lower rows 600Â and 2,000Â, respectively).
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